David Sherman, Ph.D., from the Center for Infectious Disease Research in Seattle, WA, visited June 27-28, 2016 to meet with Vanderbilt faculty and present a PMI Special Seminar, “Mining TB gene regulation to improve therapy”.
Drs. Sherman and Sterling are collaborating on projects related fluoroquinolone resistance in Mycobacterium tuberculosis and had productive discussions related to a recent grant submission.
Dr. Sherman completed his Ph.D. at Vanderbilt University and while he was on campus he visited with old colleagues and friends.
Links: